CFDE Data Portal | Search URAD

	Label	Description
	URAD associations Collection (Entity type)	Associations for URAD_associations
	URAD associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	URAD Gene (Entity type)	ENSG00000183463 - ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase
	GSE189035 inositol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE168596 2 V 3 ADIPONECTIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 3 V 2 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE157050,GSE157051 2 V 3 METFORMIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 1 V 3 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125403 7 V 0 VENETOCLAX HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

URAD associations

Associations for URAD_associations

URAD associations.tsv

A file from IDG as part of the Harmonizome project

URAD

ENSG00000183463 - ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase

GSE189035 inositol 2 v 4 human dn

A Gene Set from LINCS

GSE168596 2 V 3 ADIPONECTIN MOUSE DN

A Gene Set from LINCS

GSE210655 3 V 2 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE157050,GSE157051 2 V 3 METFORMIN MOUSE DN

A Gene Set from LINCS

GSE236502 paclitaxel 1 v 3 human dn

A Gene Set from LINCS

GSE236502 1 V 3 PACLITAXEL HUMAN DN

A Gene Set from LINCS

GSE125403 7 V 0 VENETOCLAX HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.